Finance
Diabetes-focused company reports first quarter net loss of $1.2M
Published in Obesity and Diabetes Week, May 3rd, 2004
The company reported a net loss of $1,234,638, or $0.04 per share, for the quarter ended March 31, 2004, compared with a net loss of $834,158, or $0.04 per share, for the same period in 2003. Weighted-average common shares outstanding for the quarters ended March 31, 2004, and March 31, 2003, were 31.6 million and 22.6 million, respectively.
Total operating expenses were $1,241,166 and $907,651 for the quarters ended March 31, 2004 and 2003, respectively. The increase in operating expenses in the 2004 period was principally the result of higher stock...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Diabetes Pathogenesis
SREBP-1c expression in liver of diabetic mice is insulin independent - Obesity Genomics and Genetics
Genetic polymorphisms in PPAR-delta associated with obesity - Obesity and Diabetes
Overweight children at high risk for developing hyperinsulinemia - Type 2 Diabetes
Reduced lipid oxidation in muscle in type 2 diabetes may be genetic - Type 2 Diabetes Pathogenesis
Glucose induces human apolipoprotein A-II gene transcription - Angiology
Antioxidants may mediate exercise-induced drop in platelet activity - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
